Perspective Therapeutics Inc

CATXNASDAQ · US

Holders

REDUCEDStale
Lantheus Alpha Therapy, LLC
Perspective Therapeutics Inc · NASDAQ
−80,783 sh · $250.9K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Alpha Therapy, LLC
Perspective Therapeutics Inc · NASDAQ
−167,149 sh · $526.1K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Alpha Therapy, LLC
Perspective Therapeutics Inc · NASDAQ
−42,129 sh · $131.2K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Alpha Therapy, LLC
Perspective Therapeutics Inc · NASDAQ
−35,769 sh · $111.6K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Alpha Therapy, LLC
Perspective Therapeutics Inc · NASDAQ
−78,145 sh · $245.6K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Holdings, Inc.
Perspective Therapeutics Inc · NASDAQ
−35,769 sh · $111.6K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Lantheus Holdings, Inc.
Perspective Therapeutics Inc · NASDAQ
−78,145 sh · $245.6K
Filed 2 Sept 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Perspective Therapeutics Inc · NASDAQ
1,003,474 sh · $4.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Perspective Therapeutics Inc · NASDAQ
3,485,946 sh · $34.8M
Filed 30 Jun 2024SEC 13Fview source